SCHEMBL220864

SCHEMBL220864

c1ccc2c(c1)cc1c2ccc2ccc3occcc3c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.44
MAOA P21397 2/20 0.44
ERBB2 P04626 1/20 0.44
FYN P06241 1/20 0.44
ACHE P22303 1/20 0.44
AHR P35869 1/20 0.44
ALDH1A1 P00352 5/20 0.44
HSD17B10 Q99714 3/20 0.44
HIF1A Q16665 1/20 0.44
CYP1B1 Q16678 1/20 0.44
HPRT1 P00492 3/20 0.42
THRB P10828 1/20 0.39
HPGD P15428 1/20 0.39
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
ESR1 P03372 1/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15416603 0.86 ALDH1A1 (0.45) CYP1A2MAOAERBB2FYNACHE
SCHEMBL31741279 0.83 HPRT1 (0.50) CYP1A2MAOAERBB2FYNACHE
SCHEMBL6201679 0.81 CYP1A2 (0.46) CYP1A2MAOAERBB2FYNACHE
SCHEMBL22228583 0.77 HPRT1 (0.52) CYP1A2MAOAERBB2FYNACHE
SCHEMBL1866520 0.77 MTNR1A (0.48) CYP1A2MAOAFYNAHRALDH1A1
SCHEMBL30423508 0.77 MTNR1A (0.48) CYP1A2MAOAFYNAHRALDH1A1
SCHEMBL1309270 0.75 ALDH1A1 (0.50) CYP1A2MAOAERBB2FYNACHE
SCHEMBL6237203 0.74 HPRT1 (0.58) CYP1A2MAOAALDH1A1HSD17B10HIF1A
SCHEMBL31275223 0.74 HPRT1 (0.58) CYP1A2MAOAALDH1A1HSD17B10HIF1A
SCHEMBL11666288 0.74 HSD17B10 (0.48) CYP1A2MAOAALDH1A1HSD17B10HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624048-B2 Photochromic cyclic compound and curable composition containing the photochromic cyclic compound TOKUYAMA CORPORATION (JP) 2026-05-12 US claimed
EP-4313996-B1 INDENONAPHTHOPYRANS HAVING TRIALKYLSILYL AND ETHYLENICALLY UNSATURATED GROUPS TRANSITIONS OPTICAL LTD (IE) 2026-05-06 EP claimed
EP-4713397-A1 INDENONAPHTHOPYRANS HAVING PERFLUOROALKYL SUBSTITUTED ARYL / HETEROARYL SULFIDE AT POSITION-11 Transitions Optical, Ltd. (IE) 2026-03-25 EP claimed
US-20260070881-A1 Photochromic Indeno-Fused Naphthopyran Compounds, Compositions, and Articles Containing Same TRANSITIONS OPTICAL LTD (IE) 2026-03-12 US claimed
EP-4581021-A1 PHOTOCHROMIC INDENO-FUSED NAPHTHOPYRAN COMPOUNDS, COMPOSITIONS, AND ARTICLES CONTAINING SAME Transitions Optical, Ltd. (IE) 2025-07-09 EP claimed
CN-119816488-A Photochromic indeno-fused naphthopyran compounds, compositions and articles containing the same 全视线光学有限公司 2025-04-11 CN claimed
EP-4514597-A1 METHOD FOR MAKING UV AND HEVL-ABSORBING OPHTHALMIC LENSES Alcon Inc. (CH) 2025-03-05 EP claimed
US-12222587-B2 Method of producing a plastic lens having a coating layer TOKUYAMA CORPORATION (JP) 2025-02-11 US claimed
EP-4313567-B1 METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES ALCON INC (CH) 2025-01-29 EP claimed
EP-4237232-B1 METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES ALCON INC (CH) 2024-11-27 EP claimed
CN-1247604-A Novel photochromic heterocyclic fused indenonaphthopyrans PPG INDUSTRIES INC (US) 2000-03-15 CN claimed
EP-0963390-A1 PHOTOCHROMIC POLYURETHANE COATING AND ARTICLES HAVING SUCH A COATING PPG Industries Ohio, Inc. (US) 1999-12-15 EP claimed
EP-0958514-A1 NOVEL PHOTOCHROMIC HETEROCYCLIC FUSED INDENONAPHTHOPYRANS PPG Industries Ohio, Inc. (US) 1999-11-24 EP claimed
CN-1226319-A Novel photochemic heterocycllic fused indenonaphthopyrans OPTICAL TRANSFORMING CO (US) 1999-08-18 CN claimed
EP-0912908-A1 NOVEL PHOTOCHROMIC HETEROCYCLIC FUSED INDENONAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 1999-05-06 EP claimed
WO-1998037115-A1 PHOTOCHROMIC POLYURETHANE COATING AND ARTICLES HAVING SUCH A COATING PPG INDUSTRIES OHIO, INC. (US) 1998-08-27 WO claimed
WO-1998032037-A1 NOVEL PHOTOCHROMIC HETEROCYCLIC FUSED INDENONAPHTHOPYRANS PPG INDUSTRIES OHIO, INC. (US) 1998-07-23 WO claimed
US-5723072-A Photochromic heterocyclic fused indenonaphthopyrans PPG INDUSTRIES, INC. (US) 1998-03-03 US claimed
WO-1997048993-A1 NOVEL PHOTOCHROMIC HETEROCYCLIC FUSED INDENONAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 1997-12-24 WO claimed
US-5698141-A REVERSE CHARGE IN COLOR WHEN EXPOSURED TO ELECTROMAGNETIC RADIATION PPG INDUSTRIES, INC. (US) 1997-12-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260070881-A1 Photochromic Indeno-Fused Naphthopyran Compounds, Compositions, and Articles Containing Same CCND3, MRPS24, AP3S1 CYP1A2 1960/4885MAOA 4702/4885ERBB2 3823/4885
US-12624048-B2 Photochromic cyclic compound and curable composition containing the photochromic cyclic compound CCNL2, CRY2, CRY1 CYP1A2 1295/4885MAOA 1373/4885ERBB2 878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.